-
1 Comment
Amoéba S.A is currently in a long term downtrend where the price is trading 47.6% below its 200 day moving average.
From a valuation standpoint, the stock is 1626.8% more expensive than other stocks from the Basic Materials sector with a price to sales ratio of 453.9.
Finally, its free cash flow fell by 7.8% to $-808K since the same quarter in the previous year.
Based on the above factors, Amoéba S.A gets an overall score of 0/5.
| Exchange | PA |
|---|---|
| CurrencyCode | EUR |
| ISIN | FR0011051598 |
| Industry | Agricultural Inputs |
| Sector | Basic Materials |
| Market Cap | 51M |
|---|---|
| PE Ratio | None |
| Target Price | 1.26 |
| Beta | 0.97 |
| Dividend Yield | None |
Amoéba S.A. develops biological biocides for the prevention of microbiological risk for water, crop protection and health sectors. It develops applications using amoeba Willaertia magna C2c Maky. The company was incorporated in 2010 and is based in Chassieu, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALMIB.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
